Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors.

BACKGROUND Liver metastases from neuroendocrine tumors (NETs) are an accepted indication for liver transplantation (LT). Despite strict patient selection, post-LT recurrence is observed in 30%-50% of cases. Postrecurrence survival is poorly investigated as well as factors influencing postrecurrence outcomes. METHODS Consecutive patients treated at a single institution for post-LT recurrence of NET between January 1, 2004, and December 31, 2018,...